|
Display additional annotations [+]
|
| |
Fig. 2. Hes8is activated by Notch signaling. Expression of hes8, neurog1 and tubb2b in neural plate stage Xenopus embryos after injection of notch-ICD either alone (A-C) or together with six1 MO (D-F) or eya1 MO (G-I). Control side is shown on the left and injected side on the right (as indicated by blue lacZ staining). In each case, injection of notch-ICD leads to upregulation of hes8 (A, D, G) and repression of neurog1 (B, E, H) and tubb2b (C, F, I). Arrowheads indicate expression domains in developing placodes. Arrows indicate reductions in placodal expression while asterisks indicate increased expression in placodes or adjacent non-neural ectoderm. |
|
Display additional annotations [+]
| Gene |
Clone |
Species |
Stages |
Anatomy |
|
dll1
|
|
laevis
|
NF stage 14
to
NF stage 16
|
neural plate
,
Rohon-Beard neuron
,
preplacodal ectoderm
,
anterior neural ridge
,
neural progenitor cell
|
|
sox3
|
|
laevis
|
NF stage 14
to
NF stage 16
|
neural plate
,
preplacodal ectoderm
|
|
neurog2
|
|
laevis
|
NF stage 14
to
NF stage 16
|
neural plate
,
Rohon-Beard neuron
,
preplacodal ectoderm
,
neural progenitor cell
|
|
neurog1
|
|
laevis
|
NF stage 14
to
NF stage 16
|
neural plate
,
Rohon-Beard neuron
,
preplacodal ectoderm
,
neural progenitor cell
|
|
neurod1
|
|
laevis
|
NF stage 14
to
NF stage 16
|
neural plate
,
preplacodal ectoderm
|
|
hes5.4
|
|
laevis
|
NF stage 14
to
NF stage 16
|
neural plate
,
preplacodal ectoderm
|
|
pou4f4
|
|
laevis
|
NF stage 14
to
NF stage 16
|
neural plate
,
preplacodal ectoderm
|
|
| |
Fig. 3. Hes8represses neuronal determination genes. A-G, K-R: Expression of various neurogenesis genes in neural plate stage Xenopus embryos after injection of hes8 mRNA (A-G) or hes8 MO (K-R). Control side is shown on the left and injected side on the right (as indicated by blue LacZ staining). Arrowheads indicate expression domains in developing placodes. Arrows indicate reductions in placodal expression while asterisks indicate increased expression in placodes or adjacent non-neural ectoderm. Hes8 overexpression leads to repression of all markers analyzed, while Hes8 knockdown promotes expansion of hes8, neurog1, neurog2, delta1 and pou4f1.2 but reduction of sox3, neurod1 and tubb2b expression. H: Western blot after in vitro transcription and translation of hes8 in the presence or absence of hes8 MO demonstrates efficacy of hes8 MO. I: Frequency of embryos with reductions of neurogenesis genes in PPR/placodes (red) or increases of neurogenesis genes in PPR/placodes or adjacent non-neural ectoderm (blue) after hes8 MO injections (see Table 3 for numbers). Significant changes to control MO are indicated (Fisher's exact test; *: p<0.05, **: p<0.001). J: Increased placodal neurog1 expression after injection of hes8 MO is rescued by coinjection of hes8 mRNA. |
|
Display additional annotations [+]
|
| |
Fig. 4. Dose-dependent activation or repression of neurogenesis genes by Six1 and Eya1 at neural plate stages. A-F, A′-F′: Expression of various neurogenesis genes in neural plate stage Xenopus embryos after injection of low (first column, A-F) or high doses (second column, A′-F′) of gr-six1 and gr-eya1 mRNA followed by DEX activation at end of gastrulation. Control side is shown on the left and injected side on the right (as indicated by blue LcZ staining). Arrowheads indicate expression domains in developing placodes. Arrows indicate reductions in placodal expression while asterisks indicate increased expression in placodes or adjacent non-neural ectoderm. Note that embryos may have reductions in some placodes but increased expression elsewhere (A′,B′). A′′-F′′: Frequency of embryos with reductions of neurogenesis genes in PPR/placodes (red) or increases of neurogenesis genes in PPR/placodes or adjacent non-neural ectoderm (blue) after injection of different doses of gr-six1 and gr-eya1 mRNA. N: number of embryos analyzed. |
|
Display additional annotations [+]
|
| |
Fig. 5. Cell autonomous effects of Six1 and Eya1. A-C: Expression of hes8, neurog1 and tubb2b in neural plate stage Xenopus embryos after injection of a myc-tagged (mt) eya1 plasmid. Control side is shown on the left and injected side on the right (as indicated by blue LacZ staining). Arrowheads indicate expression domains in developing placodes. Arrows indicate reductions in placodal expression while asterisks indicate increased expression in placodes or adjacent non-neural ectoderm. Both hes8 and neurog1 but not tubb2b show ectopic expression. A′, B′, B′′: Ectopic expression of hes8 and neurog1 in non-neural ectoderm of embryos injected with mt-eya1 at higher magnification together with immunostaining for myc (MT). Colored arrows indicate hes8 and neurog1 expression in MT immunopositive cells. |
|
Display additional annotations [+]
|
| |
Fig. 7. Six1 activates hes8 and represses neuronal differentiation independent of Notch. A-F, H-M: Expression of hes8, neurog1 and tubb2b in neural plate stage Xenopus embryos after injection of six1 mRNA (A-C), six1 mRNA followed by DAPT treatment (D-F), six1 plus su(h)-DBM mRNA (H-J) or su(h)-DBM mRNA (K-M) alone. Control side is shown on the left and injected side on the right (as indicated by blue lacZ staining). Arrowheads indicate expression domains in developing placodes. Arrows indicate reductions in placodal expression while asterisks indicate increased expression in placodes or adjacent non-neural ectoderm. Overexpression of Six1 upregulates hes8 and represses neurog1 and tubb2b even when Notch signaling is blocked by DAPT or su(h)-DBM. G: Frequency of increased hes8 expression in PPR/placodes or adjacent non-neural ectoderm (blue) or reduced neurog1 or tubb2b expression in PPR/placodes in embryos injected with six1 and eya1 is not significantly altered by DAPT treatment (for numbers see Table 1). N: Frequency of increased hes8 expression in embryos injected with su(h)-DBM is significantly increased by coinjection of six1 and eya1 while frequency of reduced neurog1 or tubb2b expression in embryos injected with su(h)-DBM is reduced after coinjection of six1 but not eya1 (for numbers see Table 1) |
|
Display additional annotations [+]
|
| |
Fig. S4. Synergy of Six1 and Eya1 with Sox3. A-I: Expression of hes8, neurog1 and tubb2b in neural plate stage Xenopus embryos after injection of myc-tagged (mt) eya1 plasmids in conjunction with six1 plasmids and gr-sox3 mRNA without (A-C; cont.: control) or with DEX treatment at stage 11 (D-F). Control side is shown on the left and injected side on the right (as indicated by blue LacZ staining). Arrowheads indicate expression domains in developing placodes. Arrows indicate reductions in placodal expression while asterisks indicate increased expression in placodes or adjacent non-neural ectoderm. Both hes8 and neurog1 show ectopic expression in both cases, with more intense upregulation of neurog1 in the presence of sox3. Ectopic tubb2b expression is observed after coinjection of eya1 and six1 but is not increased in the presence of Sox3. |
|
Display additional annotations [+]
|
| |
Fig. S5. Eya1 activates hes8 and represses neuronal differentiation independent of Notch. A-L: Expression of hes8, neurog1 and tubb2b in neural plate stage Xenopus embryos after injection of eya1 mRNA (A-C), eya1 mRNA followed by DAPT treatment (D-F), eya1 plus su(h)-DBM mRNA (H-J) or su(h)-DBM mRNA (K-M) alone. Control side is shown on the left and injected side on the right (as indicated by blue LacZ staining). Arrowheads indicate expression domains in developing placodes. Arrows indicate reductions in placodal expression while asterisks indicate increased expression in placodes or adjacent non-neural ectoderm. Overexpression of Eya1 upregulates hes8 even when Notch signaling is blocked by DAPT or su(h)-DBM while neurog1 and tubb2b are occasionally repressed (but not significantly more frequent than after injection of su(h)-DBM). |
|
Display additional annotations [+]
|
| |
Fig. 6. Dose-dependent activation or repression of neurogenesis genes by Six1 and Eya1 at tailbud stages. A-D, A′-D′: Expression of various neurogenesis genes in tailbud stage Xenopus embryos after injection of low (A-D) or high doses (A′-D′) of gr-six1 and gr-eya1 mRNA followed by DEX activation at end of gastrulation. Control side is shown in the right and injected side in the left panels (as indicated by blue LacZ staining). Arrowheads indicate expression domains in developing placodes. Arrows indicate reductions in placodal expression while asterisks indicate increased expression in placodes or adjacent non-neural ectoderm. A′′-D′′: Frequency of embryos with reductions of neurogenesis genes in PPR/placodes (red) or increases of neurogenesis genes in PPR/placodes or adjacent non-neural ectoderm (blue) after injection of different doses of gr-six1 and gr-eya1 mRNA. N: number of embryos analyzed. |
